131 related articles for article (PubMed ID: 33340712)
41. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Fondurulia J; Chen MH; Kaplan I; Beard CJ; Tomaszewski JE; Renshaw AA; Wein A; Coleman CN
J Clin Oncol; 1999 Jan; 17(1):168-72. PubMed ID: 10458230
[TBL] [Abstract][Full Text] [Related]
42. Travel, Treatment Choice, and Survival Among Breast Cancer Patients: A Population-Based Analysis.
Longacre CF; Neprash HT; Shippee ND; Tuttle TM; Virnig BA
Womens Health Rep (New Rochelle); 2021; 2(1):1-10. PubMed ID: 33786524
[No Abstract] [Full Text] [Related]
43. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
44. Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer.
Tan WS; Krimphove MJ; Cole AP; Marchese M; Berg S; Lipsitz SR; Löppenberg B; Nabi J; Abdollah F; Choueiri TK; Kibel AS; Sooriakumaran P; Trinh QD
Clin Genitourin Cancer; 2019 Oct; 17(5):e1060-e1068. PubMed ID: 31303561
[TBL] [Abstract][Full Text] [Related]
45. Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Huland E; Scardino PT; Kattan MW; Huland H
J Urol; 2002 Mar; 167(3):1306-9. PubMed ID: 11832719
[TBL] [Abstract][Full Text] [Related]
46. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y
Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412
[TBL] [Abstract][Full Text] [Related]
47. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.
Preisser F; Chun FKH; Pompe RS; Heinze A; Salomon G; Graefen M; Huland H; Tilki D
Eur Urol; 2019 Jul; 76(1):106-114. PubMed ID: 30772034
[TBL] [Abstract][Full Text] [Related]
48. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.
Khan MA; Han M; Partin AW; Epstein JI; Walsh PC
Urology; 2003 Jul; 62(1):86-91; discussion 91-2. PubMed ID: 12837428
[TBL] [Abstract][Full Text] [Related]
49. Residual prostatic tumour in the surgical bed following radical prostatectomy in organ-confined prostate cancer: possible prognostic significance.
Valotto C; Falconieri G; Pizzolitto S; Cerruto MA; Brondani G; De Gobbi A; Zattoni F
Arch Ital Urol Androl; 2011 Jun; 83(2):78-82. PubMed ID: 21826879
[TBL] [Abstract][Full Text] [Related]
50. Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group.
Patel HD; Tosoian JJ; Carter HB; Epstein JI
JAMA Oncol; 2018 Jan; 4(1):89-92. PubMed ID: 28715578
[TBL] [Abstract][Full Text] [Related]
51. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy.
Blute ML; Bostwick DG; Bergstralh EJ; Slezak JM; Martin SK; Amling CL; Zincke H
Urology; 1997 Nov; 50(5):733-9. PubMed ID: 9372884
[TBL] [Abstract][Full Text] [Related]
52. Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice.
Sanmamed N; Glicksman RM; Herrera-Caceres J; Lehrer EJ; Heaton J; Hansen AR; Chung P; Fleshner NE; Den RB; Zaorsky NG; Berlin A
Urol Oncol; 2020 Nov; 38(11):848.e1-848.e7. PubMed ID: 32553790
[TBL] [Abstract][Full Text] [Related]
53. Prediction of Biochemical Recurrence Following Radiotherapy among Patients with Persistent PSA after Radical Prostatectomy: A Single-Center Experience.
Xiang C; Liu X; Chen S; Wang P
Urol Int; 2018; 101(1):47-55. PubMed ID: 29627830
[TBL] [Abstract][Full Text] [Related]
54. Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy.
Cho HL; Murthy V; Mouw KW; D'Amico AV; Nguyen PL; Leeman JE; Dee EC
Prostate; 2022 Aug; 82(11):1098-1106. PubMed ID: 35652585
[TBL] [Abstract][Full Text] [Related]
55. Comparison of Perioperative and Early Oncologic Outcomes between Open and Robotic Assisted Laparoscopic Prostatectomy in a Contemporary Population Based Cohort.
Pearce SM; Pariser JJ; Karrison T; Patel SG; Eggener SE
J Urol; 2016 Jul; 196(1):76-81. PubMed ID: 26860793
[TBL] [Abstract][Full Text] [Related]
56. Low detectable prostate specific antigen after radical prostatectomy--treat or watch?
Koulikov D; Mohler MC; Mehedint DC; Attwood K; Wilding GE; Mohler JL
J Urol; 2014 Nov; 192(5):1390-6. PubMed ID: 24859441
[TBL] [Abstract][Full Text] [Related]
57. Impact of travel burden on the treatment of stage I and II breast cancer: A National Cancer Database analysis.
Perry NJ; Sharon CE; Tortorello GN; Ma KL; Straker RJ; Fayanju OM; Tchou JC; Miura JT; Karakousis GC
Surgery; 2023 Oct; 174(4):794-800. PubMed ID: 37562985
[TBL] [Abstract][Full Text] [Related]
58. Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma: effect of early adjuvant radiation therapy on biochemical control.
Valicenti RK; Gomella LG; Ismail M; Mullholland SG; Petersen RO; Corn BW
Cancer; 1998 May; 82(10):1909-14. PubMed ID: 9587124
[TBL] [Abstract][Full Text] [Related]
59. Clinical Outcomes of Postoperative Radiotherapy Following Radical Prostatectomy in Patients with Localized Prostate Cancer: A Multicenter Retrospective Study (KROG 18-01) of a Korean Population.
Lee SU; Cho KH; Park W; Cho WK; Kim JS; Wee CW; Kim YS; Kim JH; Nam TK; Cho J; Jeong SM; Kim Y; Shim SJ; Choi Y; Kim JS
Cancer Res Treat; 2020 Jan; 52(1):167-180. PubMed ID: 31291715
[TBL] [Abstract][Full Text] [Related]
60. Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome.
Zietman AL; Edelstein RA; Coen JJ; Babayan RK; Krane RJ
Urology; 1994 Jun; 43(6):828-33. PubMed ID: 7515206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
